266 related articles for article (PubMed ID: 37010572)
1. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.
Sherawat K; Mehan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1647-1667. PubMed ID: 37010572
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
Subedi L; Gaire BP
Pharmacol Res; 2021 Jul; 169():105661. PubMed ID: 33971269
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
4. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
5. Analysis of tanshinone IIA induced cellular apoptosis in leukemia cells by genome-wide expression profiling.
Liu C; Li J; Wang L; Wu F; Huang L; Xu Y; Ye J; Xiao B; Meng F; Chen S; Yang M
BMC Complement Altern Med; 2012 Jan; 12():5. PubMed ID: 22248096
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA alleviates NLRP3 inflammasome-mediated pyroptosis in Mycobacterium tuberculosis-(H37Ra-) infected macrophages by inhibiting endoplasmic reticulum stress.
Li Y; Fu Y; Sun J; Shen J; Liu F; Ning B; Lu Z; Wei L; Jiang X
J Ethnopharmacol; 2022 Jan; 282():114595. PubMed ID: 34517060
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone IIA protected against lipopolysaccharide-induced brain injury through the protective effect of the blood-brain barrier and the suppression of oxidant stress and inflammatory response.
Wang X; Wang WM; Han H; Zhang Y; Liu JL; Yu JY; Liu HM; Liu XT; Shan H; Wu SC
Food Funct; 2022 Aug; 13(15):8304-8312. PubMed ID: 35839080
[TBL] [Abstract][Full Text] [Related]
8. RasGRF1 participates in the protective effect of tanshinone IIA on depressive like behaviors of a chronic unpredictable mild stress induced mouse model.
Cheng Y; An Q; Wang J; Wang Y; Dong J; Yin J
Gene; 2020 Sep; 754():144817. PubMed ID: 32473965
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic Extract and Tanshinone IIA Derived from
Zhang XW; Zhou M; An L; Zhang P; Li P; Chen J
Am J Chin Med; 2020; 48(6):1455-1473. PubMed ID: 32933312
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA improves degranulation of mast cells and allergic rhinitis induced by ovalbumin by inhibiting the PLCγ1/PKC/IP3R pathway.
Li S; Li Z; Tan T; Dai S; Wu Y; Xu F
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S702-S710. PubMed ID: 34792426
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
Deng H; Yu B; Li Y
Phytother Res; 2021 Aug; 35(8):4309-4323. PubMed ID: 34169595
[TBL] [Abstract][Full Text] [Related]
12. The application of omics techniques to evaluate the effects of Tanshinone IIA on dextran sodium sulfate induced ulcerative colitis.
Zhu G; Wu X; Jiang S; Wang Y; Kong D; Zhao Y; Wang W
Mol Omics; 2022 Aug; 18(7):666-676. PubMed ID: 35670211
[TBL] [Abstract][Full Text] [Related]
13. A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza.
Cui S; Chen S; Wu Q; Chen T; Li S
Int Immunopharmacol; 2020 Apr; 81():106040. PubMed ID: 31818704
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA protects PC12 cells from β-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway.
Dong H; Mao S; Wei J; Liu B; Zhang Z; Zhang Q; Yan M
Mol Biol Rep; 2012 Jun; 39(6):6495-503. PubMed ID: 22314911
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Ameliorates Progression of CAD Through Regulating Cardiac H9c2 Cells Proliferation and Apoptosis by miR-133a-3p/EGFR Axis.
Xu H; Li H; Zhu P; Liu Y; Zhou M; Chen A
Drug Des Devel Ther; 2020; 14():2853-2863. PubMed ID: 32764884
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone IIA suppresses lipopolysaccharide-induced neuroinflammatory responses through NF-κB/MAPKs signaling pathways in human U87 astrocytoma cells.
Jin H; Peng X; He Y; Ruganzu JB; Yang W
Brain Res Bull; 2020 Nov; 164():136-145. PubMed ID: 32860868
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Ang2/Tie2 Axis with Tanshinone IIA Elicits Vascular Normalization in Ischemic Injury and Colon Cancer.
Zou W; Qian C; Zhang S; Wan X; Wei Z; Li X; Wu Y; Chen W; Wang A; Zhao Y; Lu Y
Oxid Med Cell Longev; 2021; 2021():7037786. PubMed ID: 34804370
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt/mTOR/p70S6K pathway in a murine model of systemic sclerosis.
Jiang Y; Hu F; Li Q; Shen C; Yang J; Li M
Int Immunopharmacol; 2019 Dec; 77():105968. PubMed ID: 31704290
[TBL] [Abstract][Full Text] [Related]
20. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
